These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 33326608

  • 1. Burden of increasing opioid use in the treatment of migraine: Results from the Migraine in America Symptoms and Treatment Study.
    Lipton RB, Buse DC, Dodick DW, Schwedt TJ, Singh P, Munjal S, Fanning K, Bostic Bs R, Reed ML.
    Headache; 2021 Jan; 61(1):103-116. PubMed ID: 33326608
    [Abstract] [Full Text] [Related]

  • 2. Characterization of Acute Prescription Migraine Medication Use: Results From the CaMEO Study.
    Hutchinson S, Lipton RB, Ailani J, Reed ML, Fanning KM, Adams AM, Buse DC.
    Mayo Clin Proc; 2020 Apr; 95(4):709-718. PubMed ID: 32247344
    [Abstract] [Full Text] [Related]

  • 3. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.
    Lipton RB, Munjal S, Alam A, Buse DC, Fanning KM, Reed ML, Schwedt TJ, Dodick DW.
    Headache; 2018 Oct; 58(9):1408-1426. PubMed ID: 30341895
    [Abstract] [Full Text] [Related]

  • 4. Opioid use and dependence among persons with migraine: results of the AMPP study.
    Buse DC, Pearlman SH, Reed ML, Serrano D, Ng-Mak DS, Lipton RB.
    Headache; 2012 Jan; 52(1):18-36. PubMed ID: 22268775
    [Abstract] [Full Text] [Related]

  • 5. Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
    Lipton RB, Hutchinson S, Ailani J, Reed ML, Fanning KM, Manack Adams A, Buse DC.
    Headache; 2019 Nov; 59(10):1762-1772. PubMed ID: 31544244
    [Abstract] [Full Text] [Related]

  • 6. Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study.
    Schwedt TJ, Alam A, Reed ML, Fanning KM, Munjal S, Buse DC, Dodick DW, Lipton RB.
    J Headache Pain; 2018 May 24; 19(1):38. PubMed ID: 29797100
    [Abstract] [Full Text] [Related]

  • 7. Characterizing opioid use in a US population with migraine: Results from the CaMEO study.
    Lipton RB, Buse DC, Friedman BW, Feder L, Adams AM, Fanning KM, Reed ML, Schwedt TJ.
    Neurology; 2020 Aug 04; 95(5):e457-e468. PubMed ID: 32527971
    [Abstract] [Full Text] [Related]

  • 8. Rates and reasons for discontinuation of triptans and opioids in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
    Holland S, Fanning KM, Serrano D, Buse DC, Reed ML, Lipton RB.
    J Neurol Sci; 2013 Mar 15; 326(1-2):10-7. PubMed ID: 23394974
    [Abstract] [Full Text] [Related]

  • 9. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC, Serrano D, Reed ML, Kori SH, Cunanan CM, Adams AM, Lipton RB.
    Headache; 2015 Jun 15; 55(6):825-39. PubMed ID: 25881857
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study.
    Buse DC, Reed ML, Fanning KM, Bostic R, Dodick DW, Schwedt TJ, Munjal S, Singh P, Lipton RB.
    J Headache Pain; 2020 Mar 02; 21(1):23. PubMed ID: 32122324
    [Abstract] [Full Text] [Related]

  • 13. Headache characteristics and burden from chronic migraine with medication overuse headache: Cross-sectional observations from the Medication Overuse Treatment Strategy trial.
    Schwedt TJ, Hentz JG, Sahai-Srivastava S, Spare NM, Martin VT, Treppendahl C, Digre K, Bennett NL, Birlea M, Watson D, Murinova N, Robert T, Dodick DW, MOTS Investigators.
    Headache; 2021 Feb 02; 61(2):351-362. PubMed ID: 33432635
    [Abstract] [Full Text] [Related]

  • 14. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
    Buse D, Manack A, Serrano D, Reed M, Varon S, Turkel C, Lipton R.
    Headache; 2012 Jan 02; 52(1):3-17. PubMed ID: 22106869
    [Abstract] [Full Text] [Related]

  • 15. Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study.
    Lipton RB, Munjal S, Buse DC, Alam A, Fanning KM, Reed ML, Schwedt TJ, Dodick DW.
    Headache; 2019 Sep 02; 59(8):1310-1323. PubMed ID: 31410844
    [Abstract] [Full Text] [Related]

  • 16. Burden of Illness Among People with Migraine and ≥ 4 Monthly Headache Days While Using Acute and/or Preventive Prescription Medications for Migraine.
    Buse DC, Yugrakh MS, Lee LK, Bell J, Cohen JM, Lipton RB.
    J Manag Care Spec Pharm; 2020 Oct 02; 26(10):1334-1343. PubMed ID: 32678721
    [Abstract] [Full Text] [Related]

  • 17. The Effect of Psychiatric Comorbidities on Headache-Related Disability in Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
    Lipton RB, Seng EK, Chu MK, Reed ML, Fanning KM, Adams AM, Buse DC.
    Headache; 2020 Sep 02; 60(8):1683-1696. PubMed ID: 33448374
    [Abstract] [Full Text] [Related]

  • 18. Impact of Depression and Anxiety Symptoms on Patient-Reported Outcomes in Patients With Migraine: Results From the American Registry for Migraine Research (ARMR).
    Pearl TA, Dumkrieger G, Chong CD, Dodick DW, Schwedt TJ.
    Headache; 2020 Oct 02; 60(9):1910-1919. PubMed ID: 32749685
    [Abstract] [Full Text] [Related]

  • 19. A Real-World Analysis of Patient Characteristics, Treatment Patterns, and Level of Impairment in Patients With Migraine Who are Insufficient Responders vs Responders to Acute Treatment.
    Lombard L, Ye W, Nichols R, Jackson J, Cotton S, Joshi S.
    Headache; 2020 Jul 02; 60(7):1325-1339. PubMed ID: 32510611
    [Abstract] [Full Text] [Related]

  • 20. Lifetime history of an anxiety or depression disorder and adherence to medications used for the acute treatment of migraine.
    Butler N, Snyder IC, Korn TG, Nicholson RA, Robbins MS, Seng EK.
    Headache; 2023 Mar 02; 63(3):368-376. PubMed ID: 36752627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.